Stock IMTX IMMATICS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Immatics N.V.

Equities

IMTX

NL0015285941

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/05/2024 am IST 		5-day change 1st Jan Change
10.81 USD +8.86% Intraday chart for Immatics N.V. +6.50% +2.66%
17/04 Certain Ordinary Shares of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024. CI
17/04 Certain Warrants of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Gain Pre-Bell Thursday
Sector Update: Health Care
Immatics Swings to 2023 Net Loss, Revenue Falls -- Shares Down Pre-Bell
Immatics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
Sector Update: Health Care Stocks Mixed Premarket Thursday
Immatics Prices $175 Million Share Offering
Immatics Plans Common Stock Offering
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Immatics N.V. Reports Interim Clinical Data from ACTengine IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRame in an Ongoing Phase 1 Trial
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation
Immatics N.V. Receives FDA Regenerative Medicine Advanced Therapy Designation for ACTengine(R) IMA203 TCR-T Monotherapy
Aktien New York Schluss: Weitere Gewinne nach jüngstem Rücksetzer
Aktien New York: Weitere Gewinne nach jüngstem Rücksetzer
Moderna se asocia con Immatics para impulsar el desarrollo de vacunas contra el cáncer
Moderna : collaboration stratégique avec Immatics
Moderna und Immatics schmieden Milliardendeal für Krebsmedikamente
Moderna, Immatics to Collaborate to Develop Novel Cancer Therapies
Moderna intensifica sus esfuerzos contra el cáncer con una nueva asociación -- Market Talk
Moderna, Immatics to work jointly on cancer vaccines
Moderna, Immatics to collaborate for cancer vaccines
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMTX Stock
  4. News Immatics N.V.
  5. Other languages